FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Patient Preference Info in Product Life Cycle

FDA publishes a draft guidance on incorporating voluntary patient preference information in medical device total life cycle regulatory decisions.

latest-news-card-1
Federal Register

Info Collection on Pediatric Device Development

Federal Register notice: FDA sends to OMB an information collection reinstatement entitled Yale-Mayo Clinic Centers of Excellence in Regulatory Scienc...

latest-news-card-1
Medical Devices

Abbott Recalls FreeStyle Libre 3 Sensors

Abbott Diabetes Care recalls (Class 1) three lots of its FreeStyle Libre 3 sensors after finding that a small number of them may provide incorrect hig...

latest-news-card-1
Medical Devices

Medtronic Laryngoscope Recall is Class 1

FDA says a July Medtronic recall of some McGrath MAC Video Laryngoscopes due to potential battery problems is Class 1.

latest-news-card-1
Human Drugs

Glenmark Pays $25 Million in False Claims Case

The Justice Department says Glenmark Pharmaceuticals, a generic drug manufacturer in Mahwah, NJ, will pay $25 million to resolve civil claims involvin...

latest-news-card-1
Medical Devices

Breas Medical Recalls Vivo 45 LS Ventilators

Breas Medical recalls (Class 1) its Vivo 45 LS ventilators to update the use instructions after internal testing identified the potential for a short-...

latest-news-card-1
Human Drugs

Lilly Reports Positive Data in Weekly Insulin Trials

Eli Lilly says data from two Phase 3 clinical trials evaluating once-weekly insulin efsitora alfa in adults with Type 2 diabetes showed non-inferiorit...

latest-news-card-1
Human Drugs

FDA Overdue on 2,000 Drug Plant Inspections: AP

An Associated Press analysis says FDA is overdue on some 2,000 drug company facilities that havent been inspected since before the Covid-19 pandemic.

latest-news-card-1
Human Drugs

Committee to Consider Iterum Sulopenem NDA

FDA asks its Antimicrobial Drugs Advisory Committee whether an Iterum NDA for sulopenem etzadroxil/probenecid to treat some uncomplicated urinary trac...

latest-news-card-1
Human Drugs

Group Seeks Clarity on Use-Related Risk Analyses

Biosimilars Forum asks FDA for further information and clarification on certain areas of the agencys recent draft guidance entitled Purpose and Conten...